Neudle.com: serotonin syndrome

Differential
(Click to cross reference)

acalculia

acetaminophen

acetylcholine

acetylcholine in CNS

acute toxic leukoencephalopathy

addiction, heroin

addiction, heroin-neurologic complications with

adolescent medicine

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

Alzheimer's disease, treatment of

aneurysm, intracranial

angina pectoris

angiography, cerebral, beaded vessels

angiography, cerebral

anorectics

anterior choroidal artery

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticonvulsants

anticonvulsants, blood level determination of

antidepressant

anxiety

aortic valve, insufficiency

aortic valve, lesion of

aprazolam

arrhythmia, cardiac

arterial dissection

arterial dissection, carotid

arterial dissection, vertebral

arteriovenous malformation

aspirin

atrial fibrillation

attention deficit disorder with hyperactivity

atypical

aura

autism

autonomic dysfunction

azidodeoxythymidine

behavior

behavior modification

behavior, combative

behavioral disorder

benzodiazepine

beta adrenergic blocker

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

calcium antagonist

Call-Fleming syndrome

cardiovascular disease

cerebellar infarction

cerebrospinal fluid, hydroxyindoleacetic acid, 5(5-HIAA)

cerebrospinal fluid, serotonin

cerebrovascular accident

cerebrovascular accident, multiple

cerebrovascular accident, rehabilitation of

cerebrovascular accident, silent

cerebrovascular accident, women

cerebrovascular accident, young adult

cerebrovascular disease

chemotherapy, CNS treatment and complications with

concentration, impaired

confusion

contraindications

controversies in neurology

conversion reaction

coronary artery disease

coronary artery spasm

creatine phosphokinase(CPK)elevated

dementia, treatment of

deprenyl

depression

depression, treatment of

desipramine

DHE

diabetes mellitus

diabetes mellitus, neurologic manifestations of

diagnostic criteria

differential diagnosis

dilantin

disability rating scale, neurological

disability, neurological

doppler, transcranial

drowsiness

drug abuse

drug abuse, neurologic complications of

drug dependence

drug induced neurologic disorders

electrocardiogram, abnormal

electroconvulsive therapy

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, triphasic delta waves

eletriptan

emergencies, neurologic

epidemiology of neurology

episodic disorders

eptinezumab

ergotamine

evidence-based research

genetic neurologic disorders

Gilles de la Tourette syndrome

hallucination, hypnagogic

hallucination, visual

headache, chronic daily

headache, classification

headache, drug induced

headache, episodic

headache, postictal

headache, precipitating factors

headache, prophylaxis

headache, rebound

headache, recurrent

headache, severe

headache, thunderclap

headache, treatment of

heralding manifestation

herbs

homovanillic acid

Huntington's chorea

hydroxyindole acetic acid 5(5HIAA)

hydroxytryptophan L-5(L-5 HTP)

hyponatremia with cerebral disorders

hyponatremic encephalopathy

iatrogenic neurologic disorders

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inattention

interferon

intracerebral hemorrhage

intracerebral hemorrhage, multiple

intracranial hemorrhage

intranasal medication

ischemic colitis

lasmiditan

L-dopa

L-dopa, drug interactions with and side effects of

left-right orientation

lethargy

leukocytosis

leukoencephalopathy

leukoencephalopathy, acute

leukoencephalopathy, toxic

level of consciousness, decreased

lifestyle

lithium

lorazepam

malignant hyperpyrexia

medication withdrawal

medulla oblongata

MELAS syndrome

memory

memory, evaluation of

memory, impairment of

meningitis, carcinomatous

menses

mental status, abnormal

microhemorrhage, intracerebral

migraine, pathogenesis

migraine, pregnancy

migraine, prophylaxis

migraine, transformed

migraine, treatment of

mimics

misdiagnosis

mitral valve lesion

mitral valve regurgitation

mitral valve stenosis

moclobemide

monoamine oxidase inhibitors

monoamines

monoamines, brain

monoclonal antibodies

mortality

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, psychogenic

MRI, abnormal

MRI, angiography

MRI, angiography, false negative

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, negative

muscle relaxant

myocardial infarction

myocardial infarction, acute

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neuropathic pain scale

neuropathy, peripheral, treatment

nonsteroidal anti-inflammatory drug

norepinephrine

nortriptyline

obesity

obsessive-compulsive disorder

orthostatic hypotension

pain, management of chronic

Parkinson disease, drug induced

Parkinson disease, juvenile

Parkinson disease, nonmotor problems of

Parkinson disease, progression

Parkinson disease, treatment of

Parkinsonism hyperpyrexia syndrome

Parkinsonism syndrome

paroxetine

pathologic reflex

patient information and support

peptides, brain

perseveration

Persistent postural-perceptual dizziness

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive supranuclear palsy

propranolol

psychiatric disorder

psychiatric problems in neurologic disorders

psychosis

psychotic behavior

pulmonary hypertension

pupil, dilated, bilateral

quality of life

quetiapine

recurrent

regional cerebral blood flow

rehabilitation for neurologic disorders

REM sleep

renal failure

renal failure, acute

reserpine and reserpine like drugs

respiratory failure

respiratory tract infection

retroperitoneal fibrosis

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

risk-benefit assessment

seizure, complications following

seizure, treatment of

selective norepinephrine reuptake inhibitor

selective serotonin reuptake inhibitors

serotonin

serotonin agonist

serotonin antagonist

serotonin norepinephrine reuptake inhibitors

sleep pathology and physiology

steroid therapy, CNS treatment and complications with

stimulant drugs

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

subarachnoid hemorrhage, nonaneurysmal

sudden death

sudden infant death syndrome

sumatriptan

sweating

symmetric brain lesions

tetrahydroaminoacridine

transient ischemic attack

trazodone

treatment of neurologic disorder

tremor

tricuspid valve, lesion of

tricyclic antidepressant

trigeminal nucleus

trigeminovascular system

triptans

trismus

urine test in toxic screen

vagus nerve stimulation

varicella zoster virus

varicella zoster virus, encephalitis

vasculitides, benign cerebral

vasculopathy

vasoactive substances

von Willebrand factor

Showing articles 150 to 190 of 190 << Previous

Increase of Parkinson Disability after Fluoxetine Medication
Neurol 43:211-213, Steur,E.N.H.J., 1993

Sumatriptan and Chest Pain
Lancet 341:1564-1565, Hillis,W.S.&MacIntyre,P.D., 1993

Transmural Myocardial Infarction with Sumatriptan
Lancet 341:861-862, Ottervanger,J.P.,et al, 1993

Efficacy of Subcutaneous Sumatriptan in Repeated Episodes of Migraine
Neurol 43:1363-1368, Cady,R.K.,et al, 1993

Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993

Postmarketing Study of Cardiovascular Adverse Reactions Associated with Sumatriptan
BMJ 307:1185, Ottervanger,J.P.,et al, 1993

Valve Disease Associated with Ergot Alkaloid Use:Echocardiographic and Pathologic Correlations
Ann Int Med 117:50-52, Redfield,M.M.,et al, 1992

Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992

Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992

Sumatriptan:Efficacy and Contribution to Migraine Mechanisms
JNNP 55:1103-1105, Pearce,J.M.S., 1992

Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992

Sumatriptan for Migraine
The Medical Letter, 34:91-931992., , 1992

Dose Ranging Efficacy & Safety of Subcut Sumatriptan in Acute Treat of Migraine
Arch Neurol 49:1271-1276, Mathew,N.T.,et al, 1992

Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991

Treatment of Acute Migraine with Subcutaneous Sumatriptan
JAMA 265:2831-2835, Cady,R.K.,et al, 1991

Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group, NEJM 325:316-321, 353-354991., , 1991

Migraine Pain Associated with Middle Cerebral Artery Dilatation:Reversal by Sumatriptan
Lancet 338:13-17, Friberg,L.,et al, 1991

Treatment of Acute Cluster Headache with Sumatriptan
The Sumatriptan Cluster Headache Study Group, NEJM 325:322-326, 353-354991., , 1991

Cocaine-Related Vascular Headahces
JNNP 54:803-806, Dhuna,A.,et al, 1991

Sumatriptan in Migraine, May be Better than Aspirin and Metoclopramide
BMJ 303:1491, Pearce,J.M.S., 1991

Advances in Cluster Headache
Neurologic Clinics, 8:867-8901990., Mathew,N.T., 1990

Migrainelike Headache and Cocaine use
JAMA 261:2995-2996, Satel,S.L.&Gawin,F.H., 1989

Pleural and Retroperitoneal Fibrosis from Dihydroergotamine
NEJM 321:1760, Malaquin,F.,et al, 1989

Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989

Possible Benefit of GR43175, A Novel 5-HT1-Like Receptor Agonist for the Acute Treatment of Severe Migraine
Lancet 1:1309-1311, Doenicke,A.,et al, 1988

Carcinoid Carcinomatous Meningitis
Ann Int Med 102:779-782, Nagourney,R.A.,et al, 1985

Serotoninergic System in Dementia of the Alzheimer Type
Arch Neurol 42:1158-1161, Volicer,L.,et al, 1985

Fibrotic Processes Associated with Long-Term Ergotamine Therapy
NEJM 311:601-602, Robert,M.,et al, 1984

Arterial Complications of Migraine Treatment with Methysergide & Parenteral Ergotamine
BMJ 285:260-261, Joyce,D.A.,et al, 1982

Neurotransmitters & CNS Disease
Lancet 2:914-918, Iversen,L.L., 1982

Fenfluramine In Autism
NEJM 307:1450-1451, Ruttenberg,B.A., 1982

Progressive Supranuclear Palsy:Functional Analysis of the Response to Methysergide & Antiparkinsonian Agents
Neurol 31:1507-1518, Rafal,R.D.,et al, 1981

Lithium Carbonate Therapy for Cluster Headache, Changes in Number of Platelets, & Serotonin & Hista
Arch Neurol 37:559-563, Medina,J.L.,et al, 1980

Newer Concepts in Management of Migraine Headaches
J Med Soc N J 74:11, Haidri,N.H.,et al, 1977

Juvenile Parkinsonism Treated with Levodopa
Arch Neurol 34:244, Sachdev,K.K.,et al, 1977

Serotonin & Myoclonic Seizures
NEJM 296:101, Munsat,T.L., 1977

Long-term Therapy of Myoclonus & Other Neurologic Disorders with L-5-Hydroxytryptophan & Carbidopa
NEJM 296:70, VanWoert,M.H.,et al, 1977

Neuropharmacological Aspects of Migraine
Editorial, BMJ 339, 1975, Aug., , 1975

Neurotransmitters & the Normal & Ischemic Cerebral Circulation
NEJM 293:812, Zervas,N.T.,et al, 1975

Huntington's Chorea, Effect of Serotonin Depletion
Arch Neurol 26:282, Chase,T.,et al, 1972

Neuropsychopharmcology & the Affective Disorders
NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969

Showing articles 150 to 190 of 190 << Previous